MedKoo News:

March 22, 2024

MedKoo is excited to announce the licensing of patents pertaining to the novel compound AUTAC4 from Tohoku University, Japan. AUTAC4, a breakthrough compound, is now featured on our website at https://www.medkoo.com/products/49782. AUTAC4 is a mitochondria-targeting autophagy-targeting chimera (AUTAC). AUTAC4 downregulates cytosolic proteins and promotes targeted mitochondrial turnover via mitophagy. This groundbreaking product is safeguarded by patents including JP Patent No.: 7370579, US Patent No.: 11512084, and EP Publication No.: 3679935.

 

January 17, 2024

MedKoo has moved to a new location at 2224 Sedwick Road Suite 102, Durham, NC 27713.

 

September 22, 2022

MedKoo is pleased to announce that we were awarded a research contract by the National Institute of Health (NIH) with Contract# 75N95022P00731.

 

September 09, 2021

MedKoo is pleased to announce that we were awarded a research contract by the National Institute of Health (NIH) with Contract# 75N95021P00528: See below web page: http://www.fbodaily.com/archive/2021/09-September/16-Sep-2021/68-awd.htm